VRDN-001, a Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R) for Thyroid Eye Disease (TED): Phase 1/2 Proof of Concept in Patients with TED. American Thyroid Association Annual Meeting October 2022.

Viridian-ATA-2022-Poster-001-535